Ling Ouyang

No. 36, Sanhao Street
Shenyang, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 51 publications

KCMF1 promotes malignant progression by NXN ubiquitin-dependent degradation in ovarian cancer.

KCMF1 promotes malignant progression by NXN ubiquitin-dependent degradation in ovarian cancer.

Journal: Cell cycle (Georgetown, Tex.)

Published: February 21, 2026

HJURP upregulation, driven by transcription factor NFYA, promotes endometrial carcinoma progression via regulating RASSF8 ubiquitination.

HJURP upregulation, driven by transcription factor NFYA, promotes endometrial carcinoma progression via regulating RASSF8 ubiquitination.

Journal: Functional & integrative genomics

Published: January 08, 2026

Ferroptosis as a novel targeted therapy in gynecological malignant tumors.

Ferroptosis as a novel targeted therapy in gynecological malignant tumors.

Journal: Discover oncology

Published: November 24, 2025

NOL7 Inhibits Ovarian Cancer Progression and Suppresses Angiogenesis by Stabilizing GADD45A to Deactivate STAT3.

NOL7 Inhibits Ovarian Cancer Progression and Suppresses Angiogenesis by Stabilizing GADD45A to Deactivate STAT3.

Journal: Cancer science

Published: September 28, 2025

Tumor suppressor FBXO11 drives ubiquitin proteasomal degradation of KIF2C to limit ovarian cancer progression and is transcriptionally repressed by ZNF217.

Tumor suppressor FBXO11 drives ubiquitin proteasomal degradation of KIF2C to limit ovarian cancer progression and is transcriptionally repressed by ZNF217.

Journal: Cellular signalling

Published: November 27, 2024

Dietary protein intake and PM2.5 on ovarian cancer survival: A prospective cohort study.

Dietary protein intake and PM2.5 on ovarian cancer survival: A prospective cohort study.

Journal: Ecotoxicology and environmental safety

Published: September 30, 2024

A study on improving cancer-related fatigue and disease-related psychological variables in patients with cervical cancer based on online mindfulness-based stress reduction: a randomized controlled trial.

A study on improving cancer-related fatigue and disease-related psychological variables in patients with cervical cancer based on online mindfulness-based stress reduction: a randomized controlled trial.

Journal: BMC women's health

Published: May 25, 2024

Long noncoding RNA VPS9D1-AS1 promotes the progression of endometrial cancer via regulation of the miR-187-3p/S100A4 axis.

Long noncoding RNA VPS9D1-AS1 promotes the progression of endometrial cancer via regulation of the miR-187-3p/S100A4 axis.

Journal: Environmental toxicology

Published: December 04, 2023

Effectiveness and safety of PD-1/PD-L1 inhibitors in advanced or recurrent endometrial cancer: a systematic review and meta-analysis.

Effectiveness and safety of PD-1/PD-L1 inhibitors in advanced or recurrent endometrial cancer: a systematic review and meta-analysis.

Journal: Frontiers in pharmacology

Published: October 31, 2023

The value of transitory protective stomas during primary debulking surgery for advanced epithelial ovarian cancer: a retrospective cohort study.

The value of transitory protective stomas during primary debulking surgery for advanced epithelial ovarian cancer: a retrospective cohort study.

Journal: International journal of surgery (London, England)

Published: October 02, 2023

Analysis of clinicopathological features and prognosis of double primary cervical cancer and ovarian cancer based on SEER database.

Analysis of clinicopathological features and prognosis of double primary cervical cancer and ovarian cancer based on SEER database.

Journal: Journal of cancer research and clinical oncology

Published: July 30, 2023

OSR1 downregulation indicates an unfavorable prognosis and activates the NF-κB pathway in ovarian cancer.

OSR1 downregulation indicates an unfavorable prognosis and activates the NF-κB pathway in ovarian cancer.

Journal: Discover oncology

Published: May 13, 2023

Showing 1-12 of 51

Last Updated: 09/26/2026